Serum investigations revealed elevated creatine kinase levels (1,898 IU/l; N<169), dyslipidemia with elevated serum triglycerides (2.29 mmol/l; N 0.57–1.71), pre-β-lipoproteins (VLDL 39%; N<30) and reduced HDL-cholesterol (0.47 mmol/l; N>0.96), apolipoprotein A1 (0.72 g/l; N 1.00–1.50) and B (0.6 g/l; N 0.7–1.2). This evidence concerns the gene APOA1 and metabolic syndrome.